Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History NRXP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics NRXP

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

NRX Pharmaceuticals Inc

NRXP
Current price
3.27 USD -0.08 USD (-2.39%)
Last closed 3.38 USD
ISIN US6294442099
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 65 921 496 USD
Yield for 12 month +35.12 %
1Y
3Y
5Y
10Y
15Y
NRXP
21.11.2021 - 28.11.2021

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware. Address: 1201 Orange Street, Wilmington, DE, United States, 19801

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

31.67 USD

P/E Ratio

Dividend Yield

Financials NRXP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures NRXP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

+4 000 USD

Last Quarter

+4 000 USD

Current Year

Last Year

-5 000 USD

Current Quarter

+2 000 USD

Last Quarter

+2 000 USD
EBITDA -17 447 750 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -191.74 %
PEG Ratio
Return On Equity TTM -682.61 %
Wall Street Target Price 31.67 USD
Revenue TTM
Book Value -1.47 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.96 USD
Diluted Eps TTM -1.96 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation NRXP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.15
Price Book MRQ 2.90

Technical Indicators NRXP

For 52 Weeks

1.10 USD 6.01 USD
50 Day MA 2.74 USD
Shares Short Prior Month 1 113 105
200 Day MA 2.19 USD
Short Ratio 2.66
Shares Short 1 196 888
Short Percent 7.72 %